Ultra Fresh

Quick links to important sections

Ultra Fresh

Method of action: Ophthalmologicals

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Ultra Fresh

Property Description
Active Ingredient Carboxymethylcellulose Sodium (CMC)
Form Ophthalmic Solution (Eye Drops), Gel, or Ointment
Pharmacological Class Ophthalmic Lubricant / Demulcent
General Purpose Temporary relief of ocular dryness and irritation
Origin Semisynthetic Polymer (derived from cellulose)

What Type of Medicine is Ultra Fresh?

Ultra Fresh is classified as an Ocular Lubricant, belonging to the therapeutic category of Ophthalmic Demulcents. These preparations are intended for topical administration to the eye. The primary purpose of this product type is to offer temporary relief from symptoms of ocular dryness, such as burning, gritty sensations, and irritation. These types of artificial tear preparations are designed to support visual function and comfort in individuals experiencing dry eye symptoms. This category of medicine is recognized for its use as an over-the-counter (OTC) option when applied according to directions.

Composition and Form: What Makes Ultra Fresh an Artificial Tear?

The identity of Ultra Fresh is defined by its key active ingredients, which are high molecular weight, semisynthetic polymers that function as viscosity-enhancing agents. These typically include Carboxymethylcellulose Sodium (CMC), a cellulose derivative, which may be used alone or in combination with other liquid polyols like Polyethylene Glycol 400 (PEG 400) or Glycerin. This combination allows the solution to mimic the consistency of natural tears. The Ultra Fresh product line is differentiated by formulations that target different needs, such as higher-viscosity variants intended for nocturnal use (P.M. variants) or specialized formulas marketed for relief associated with prolonged screen exposure. The finished product is available most commonly as an Ophthalmic solution (eye drops), built on an aqueous-based vehicle, and can be manufactured as a single active ingredient product or a combination product, frequently available in preservative-free formats for sensitive eyes.

Regulatory References

  1. National Institutes of Health (NIH)

What side effects are possible with Ultra Fresh?

Possible Side Effects and Safety Information

The safety profile for Ultra Fresh, which contains Carboxymethylcellulose Sodium as an ophthalmic lubricant, is characterized by a low incidence of systemic adverse reactions, as minimal systemic absorption occurs. Regulatory documentation organizes potential adverse reactions primarily within the Eye Disorders System Organ Class (SOC), reflecting the product’s local action.

Frequency and Common Ocular Effects

Adverse reactions are predominantly localized and are classified by regulatory authorities based on frequency. Many common effects occur shortly after application and are considered transient:

  • Common effects listed in official documents include eye irritation (such as stinging or burning), transient blurred vision, ocular hyperemia (redness of the eye), increased lacrimation (tearing), and eye pruritus (itching).

Safety Considerations and Discontinuation

The most significant safety consideration is the possibility of Hypersensitivity Reactions, which fall under the Immune System Disorders SOC. Although the frequency of severe allergic responses is generally Not Known from available data, official labels note that such reactions necessitate prompt medical assessment and discontinuation of the product.

Regulatory documents mandate discontinuation if symptoms persist or worsen. Users must stop using the product and seek re-assessment if they experience eye pain, changes in vision, or continued/increased redness or irritation that lasts beyond a specified duration. Due to minimal absorption, specific dose adjustments are not typically required for older adults or those with renal or hepatic impairment. However, use during pregnancy and lactation may be subject to a risk-benefit assessment by a healthcare provider.

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory profile for Ultra Fresh (Carboxymethylcellulose Sodium Ophthalmic Solution) is defined by a negligible systemic risk due to its composition and route of administration.

Overdose Scope

Feature Official Regulatory Statement
Documented Manifestations No specific systemic signs or symptoms are documented for topical ocular overdose, as the substance is pharmacologically inert.
Physiological Systems Affected Systemic intoxication is not expected following topical use due to the high molecular weight and negligible absorption.
Immediate Action Required Seek immediate medical attention or contact a Poison Control Center for known or suspected accidental oral ingestion.
Severity Classification Topical overdose is classified by regulatory authorities as presenting no hazard or no danger.

Official Overdose Statements

  • Systemic intoxication is not expected following topical ocular administration.
  • The high molecular weight of the active substance confirms that accidental overdose presents no hazard.
  • No specific antidote is known for this compound.
  • Management of any overdose situation is confined to symptomatic and supportive treatment.
  • Accidental oral ingestion, particularly in children, is the primary scenario requiring immediate contact with emergency services.

Regulatory documents establish that the overdose profile is structured around this low systemic risk, reserving the requirement to seek urgent medical help specifically for the non-ocular exposure scenario of accidental oral ingestion.

Therapeutic Uses of Ultra Fresh

Quick Facts

  • Relief of Dryness: May help manage the discomfort associated with dry eyes.
  • Symptom Management: An available option for addressing burning and irritation of the eye.

Ultra Fresh is used as a therapeutic option for patients to support the management of dry eye symptoms. Its primary therapeutic domains include providing temporary relief from burning, irritation, and general discomfort that may be caused by dryness of the eye. The use of this preparation may help manage the overall condition of dry eyes.

This medication is categorized within ophthalmic lubricants and irrigations, which are designed to support lubrication of the eye surface. Ocular lubricants are available options for patients seeking to ease symptoms associated with dry eye disease.

Healthcare providers may recommend this type of therapeutic agent to assist with moistening the surface of the eye. It serves to support the maintenance of comfort for individuals experiencing the effects of ocular dryness. The intended benefit is to alleviate the feeling of discomfort. All specific questions regarding a treatment regimen and whether this medication is appropriate should be discussed with a qualified clinician.

Eligibility and Restrictions for Use

Who can and cannot use Ultra Fresh?

Official regulatory documents define population eligibility for Ultra Fresh (Carboxymethylcellulose Sodium Ophthalmic Solution) based on ingredient sensitivity and patient demographics.

Absolute Contraindication

Use is strictly contraindicated in patients with a known hypersensitivity or allergy to the active ingredient, Carboxymethylcellulose Sodium, or to any of the specific excipients present in the formulation. This is the sole absolute prohibition in the official labeling.

Eligibility by Age and Physiological State

Population Group Regulatory Status
Adults & Older Adults Permitted and constitute the standard labeled user group.
Children & Adolescents Use may be classified as not established or not recommended by some regulators due to the absence of dedicated clinical trial data.
Pregnancy & Lactation Permitted due to the topical administration and negligible systemic absorption of the medicine.
Hepatic or Renal Impairment Permitted; no specific restrictions are required based on organ function limitations.

Eligibility is generally permitted across systemic comorbidity groups because the active ingredient has minimal systemic exposure.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documentation for Ultra Fresh (Carboxymethylcellulose Sodium ophthalmic solution) indicates that its interaction profile is highly localized and physical, rather than systemic. Due to the high molecular weight of the active ingredient, its absorption into the bloodstream is negligible, which eliminates concerns regarding typical systemic drug–drug interactions.

Documented Interaction Profile

No systemic interactions with oral medications, CYP enzymes, drug transporters, food, alcohol, or herbal supplements are documented in official regulatory labels.

Interacting Substance Class Interaction Type Restriction/Timing Rule
Topical Ophthalmic Medicines Physical Administration Timing Mandatory separation interval of at least 5 to 15 minutes between applications.

Administration Constraints

The only official interaction constraint is a requirement for time separation when Ultra Fresh is co-administered with other eye drops, solutions, or ointments. This constraint prevents the viscous solution from physically interfering with or displacing the other medicine on the eye surface, which could delay or reduce its ocular exposure. Regulatory guidance specifies that the most viscous product in the sequence (such as a gel or ointment) must be administered last to optimize the absorption of the initial product.

Mechanism of Action

Disruption of Microbial Cell Membrane Integrity

Ultra Fresh acts primarily as a membrane disruptor. Its positively charged active component is electrostatically attracted to and embeds within the negatively charged cell membranes of targeted microorganisms (bacteria and fungi), causing immediate structural failure and depolarization . This interaction leads to an efflux of essential cellular materials and rapid cellular cytotoxicity, initiating a physiological change in microbial population density.


Inhibition of Intracellular Metabolism and Sustained Localized Action

Beyond structural damage, the drug component penetrates the cell to act as a metabolic inhibitor. It interferes with critical internal enzyme systems and the electron transport chain, preventing the cell from producing necessary energy (ATP). This action effectively restricts microbial growth and replication, supporting the overall cessation of microbial viability. Furthermore, the drug engages a mechanism of action that includes binding to the site of application. This non-covalent binding serves as a localized reservoir, facilitating the sustained maintenance of drug activity on the treated surface.

Dosage and Administration Information

How to Use Ultra Fresh

Ultra Fresh (Carboxymethylcellulose Sodium) is administered solely by the topical ophthalmic instillation route, meaning the preparation is applied directly onto the eye's surface. The regimen is defined by a non-scheduled, as-needed (prn) frequency to address symptoms of ocular dryness, with a typical application quantity of 1 or 2 drops of solution or a small strip of gel per application. While use is primarily intermittent, established guidelines specify maximum daily frequencies for reference, such as up to 4 to 8 times daily, depending on the severity of the temporary discomfort.


Official Administration Protocols

Proper use involves specific procedural requirements to maintain product sterility and ensure correct delivery.

Usage Principle Official Instruction for Proper Use
Dose Volume 1 to 2 drops or a small strip of ointment/gel.
Timing for Other Products Administer other topical eye preparations at least 5 to 15 minutes apart.
Contact Lenses Contact lenses must typically be removed before application, with reinsertion permitted after approximately 15 minutes.
Sterility Do not allow the container tip to touch the eye, eyelid, or any other surface.
Container Handling Single-dose vials must be discarded immediately after use.

Population and Regimen Rules

Administration is generally uniform across populations due to the negligible systemic absorption of the active ingredient. The standard adult dose applies to the pediatric population based on clinical experience, and no dose adjustment is required for older adults. Since the preparation is used on an as-needed basis, there are no complex missed-dose rules associated with a formal scheduled regimen. Its use is palliative, suitable for long-term intermittent application against chronic conditions.

Recent Clinical Evidence

Research Evidence / Overview of Studies

Clinical studies continually evaluate the activity of PDE-5 inhibitors (the class of drug to which Ultra Fresh belongs) across its approved indications, as well as in other areas where the biological mechanism may be relevant.


Erectile Dysfunction (ED) and Sexual Function

Research has consistently examined the role of this drug class in the management of ED. Studies using measures like the International Index of Erectile Function (IIEF) continue to serve as the primary tool for assessing treatment-related changes. Recent findings have also explored the use of PDE-5 inhibitors in combination with other agents, such as antioxidants or other classes of drugs, to evaluate potential additive benefits in complex or difficult-to-treat ED cases. Research also investigates its activity in premature ejaculation, often in combination protocols.


Pulmonary Arterial Hypertension (PAH)

In studies involving PAH, researchers continue to focus on the drug's effect on vascular resistance. Recent clinical trials have examined the impact of varying dose levels, specifically focusing on endpoints like six-minute walk distance (6MWD) and measures of clinical worsening. This research is crucial for refining standard dosing protocols and understanding long-term maintenance of the effect on pulmonary hemodynamics.


Exploratory Uses: Benign Prostatic Hyperplasia (BPH)

Ongoing clinical investigation continues to explore the drug class in relation to Benign Prostatic Hyperplasia (BPH), particularly concerning lower urinary tract symptoms (LUTS). Clinical data has noted an association between use and possible improvements in certain LUTS and pain scores, suggesting a potential future role in co-management. However, this remains an area of active research, and clinical significance is still under assessment.

Key Studies & References

  1. National Institute for Health and Care Excellence (NICE) Guideline: Chronic heart failure in adults: diagnosis and management

Frequently Asked Questions (FAQ)

Common questions about Ultra Fresh (FAQ)

Q: How quickly does Ultra Fresh usually start working?

Ultra Fresh is classified as an ocular lubricant intended for temporary relief of symptoms. The lubricating and protective effects are generally observed immediately upon application, corresponding to prompt relief from temporary discomforts like burning or irritation.


Q: Do I need a prescription to get Ultra Fresh?

According to official product information, Ultra Fresh, which contains Carboxymethylcellulose Sodium, is typically classified as an Over-the-Counter (OTC) medicine for ophthalmic use, meaning it is generally available without a prescription.


Q: Is Ultra Fresh the same type of medicine as [similar common drug name]?

Ultra Fresh is classified as an Ophthalmic Demulcent or Ocular Lubricant. Other products for dry eye symptoms may belong to the same therapeutic class but contain different active ingredients, such as Polyethylene Glycol or Hyaluronate.


Q: What is the biggest difference between Ultra Fresh and other treatments for this condition?

Differences between Ultra Fresh and other products in the same class often involve the specific polymer used (Carboxymethylcellulose Sodium) and the combination of inactive ingredients. These components contribute to the unique consistency of the product, its viscosity, and how long it is described as maintaining activity on the eye surface.


Q: Does Ultra Fresh cause sleepiness or drowsiness?

Official regulatory documents do not list sleepiness or drowsiness as documented adverse reactions. This is because Ultra Fresh is administered topically to the eye and has negligible systemic absorption, meaning minimal active ingredient enters the bloodstream.


Q: Can Ultra Fresh affect my mood or behavior?

Due to its localized mechanism of action as an ocular lubricant with minimal systemic absorption, effects on mood or behavior are not listed as documented adverse reactions in the official product information.


Q: Does Ultra Fresh interact with birth control pills?

Official documentation indicates that no systemic interactions are documented with oral medications like birth control pills. This is due to the minimal absorption of the active ingredient into the bloodstream.


Q: Why is Ultra Fresh sometimes prescribed for a different use than its main purpose?

Official documentation defines the main purpose as the temporary relief of ocular dryness and irritation. A healthcare provider may direct the use of Ultra Fresh for other specialized or adjunctive purposes, such as application following certain eye procedures.


Q: What happens if Ultra Fresh is stopped suddenly?

Since Ultra Fresh functions as a topical lubricant used for temporary relief and is not a scheduled medication, there is no risk of addiction or withdrawal symptoms described in the regulatory label upon cessation of use.


Q: Is Ultra Fresh habit-forming or addictive?

No. Official documents do not describe Ultra Fresh as habit-forming or addictive. Its classification as a topical ocular lubricant means it does not affect the central nervous system in the manner associated with dependence.


Q: Are there different strengths or formulations of Ultra Fresh?

Products containing the active ingredient, Carboxymethylcellulose Sodium, are available in a range of strengths and formulations, such as solutions, gels, or ointments. These different versions are designed to offer varying viscosity and duration of effect on the eye surface.


Q: What is the difference between a side effect and an allergic reaction to Ultra Fresh?

Official labeling distinguishes between common, transient side effects (such as mild, temporary burning or irritation) and signs of a hypersensitivity or allergic reaction. Allergic reactions, like swelling or rash, are severe safety considerations that officially mandate immediate cessation and medical attention.


Q: What type of healthcare provider typically prescribes Ultra Fresh?

As an Over-the-Counter (OTC) medicine, Ultra Fresh does not require a prescription. However, healthcare providers specializing in eye care, such as an optometrist or ophthalmologist, may discuss its use as part of a treatment plan.


Q: How are the clinical trials for Ultra Fresh described?

Clinical studies for ocular lubricants, including those with Carboxymethylcellulose Sodium, typically evaluate effects on tear film stability and subjective dry eye symptoms in comparison to other lubricants or controls. Research focuses on measures related to comfort and ocular surface changes.


Q: What does the research say about Ultra Fresh's effectiveness compared to a placebo?

Clinical research evidence suggests that the application of ocular lubricants like Ultra Fresh helps to improve tear film stability and subjective dry eye symptoms compared to non-treatment. Improvements are described in official clinical data.


Q: What is the 'safety classification' of Ultra Fresh for driving or operating machinery?

Official labeling carries a warning that application can cause transient blurred vision immediately after use. Users are advised to refrain from driving or operating machinery until their vision has completely cleared.


Q: Does Ultra Fresh affect appetite or cause weight changes?

Since Ultra Fresh has negligible systemic absorption and its documented adverse events are strictly related to the eye, systemic effects like changes in appetite or weight are not listed in the official prescribing information.


Q: Is Ultra Fresh known to cause dryness of the mouth or eyes?

Ultra Fresh is specifically used to relieve eye dryness. Systemic effects like dry mouth are not listed as the product is localized to the eye. The potential for temporary eye irritation (such as stinging) is listed as a common, transient side effect of application.


Q: Is Ultra Fresh approved for long-term continuous use?

Ultra Fresh is approved for the temporary relief of dry eye symptoms, and regulatory documents indicate it is suitable for long-term intermittent application on an as-needed basis. It is not generally described in regulatory documents as a continuous daily treatment.


Q: Where can I find the official prescribing information for Ultra Fresh?

The official product labeling, which includes the full prescribing information, is published on government-supported repositories. These include services such as the FDA DailyMed and the NIH MedlinePlus drug information pages.


Q: Is there a generic version of Ultra Fresh available?

Products containing the active ingredient, Carboxymethylcellulose Sodium, are available under various brand names and as generic-equivalent versions.


Q: How do I know if Ultra Fresh is working for me?

Ultra Fresh is considered to be working when it provides temporary relief from symptoms of burning, irritation, and discomfort due to dryness. Official guidance mandates that use be stopped and re-assessment sought if the condition worsens or persists for more than a specified duration.


Q: Is there a risk of withdrawal symptoms when stopping Ultra Fresh?

No. As a topical ocular lubricant with minimal systemic absorption, Ultra Fresh is not associated with withdrawal symptoms upon cessation.


Q: Can Ultra Fresh be taken while pregnant or breastfeeding, based on official information?

Regulatory guidance permits use during pregnancy and lactation due to the drug's topical administration and negligible systemic absorption. Official labels may still recommend a risk-benefit assessment by a healthcare provider.


Q: What are the general expectations about taking Ultra Fresh for the first month?

The primary expectation is to receive temporary relief from symptoms on an as-needed basis. It is expected that any initial mild stinging or temporary blurring of vision should be transient. If symptoms persist or worsen over a period of time, regulatory guidance instructs that use must be stopped for medical re-assessment.


Q: How long can a person generally expect to take Ultra Fresh?

Ultra Fresh is suitable for long-term intermittent application against chronic conditions on an as-needed basis. Regulatory documents do not define a maximum duration of use.


Q: What is the role of Ultra Fresh in a complete treatment plan?

The role of Ultra Fresh is defined as providing temporary relief from symptoms of ocular dryness and irritation. It functions as a palliative, supportive measure to aid comfort but does not treat the underlying cause of chronic dry eye disease.


Q: How long does the full effect of Ultra Fresh last?

The product provides sustained maintenance of drug activity on the treated surface due to its viscosity-enhancing polymer. The duration of symptomatic relief is variable based on the individual's condition and environment, but a specific numerical timeframe is not formally documented in regulatory labels.


Q: Can Ultra Fresh be used by children, and if so, what is the age limit described?

Regulatory information indicates that the standard adult dose is often applied to the paediatric population based on clinical experience. However, some regulators state that the use may be classified as not established due to a lack of dedicated clinical trial data in children.


Q: Are there any specific patient warnings for people with a history of heart issues?

There are no specific warnings or restrictions for patients with a history of heart issues described in the official product label. This is because the medicine is topically administered and has negligible systemic absorption.

How should Ultra Fresh be stored and disposed of?

How to Store and Dispose of Ultra Fresh

The storage and disposal instructions for Ultra Fresh (Carboxymethylcellulose Sodium ophthalmic solution) must be followed to ensure product quality and safety, as defined by official regulatory labeling.


Official Storage Conditions

Requirement Instruction
Temperature Store at room temperature, typically 15 C–30 C (59 F–86 F).
Protection Protect the container from direct sunlight and extreme temperatures.
Child Safety Keep out of the sight and reach of children.

Handling and Disposal Rules

Multi-dose bottles must be discarded 90 days after opening. To prevent contamination, do not touch the container tip to any surface, and keep the cap tightly closed after each use. Unused or expired medication should be disposed of by utilizing a drug take-back program or by mixing with an undesirable substance and placing in a sealed container for the household trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Ultra Fresh found in:

A-Z Index: